We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATH icon
2276
Nathan's Famous
NATH
$403M
$868K ﹤0.01%
11,106
-2,265
-17% -$155K
HUSV icon
2277
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$84.7M
$866K ﹤0.01%
+32,664
New +$839K
KW
2278
DELISTED
Kennedy-Wilson Holdings
KW
$865K ﹤0.01%
42,062
-368
-0.9% -$7.83K
AIMT
2279
DELISTED
Aimmune Therapeutics
AIMT
$865K ﹤0.01%
41,565
-12,399
-23% -$255K
CHN
2280
DELISTED
China Fund
CHN
$864K ﹤0.01%
42,694
+1,899
+5% +$38.1K
MFM
2281
Aberdeen Municipal Income Fund
MFM
$223M
$863K ﹤0.01%
123,629
-3,737
-3% -$25.7K
NS
2282
DELISTED
NuStar Energy L.P.
NS
$863K ﹤0.01%
31,803
-4,395
-12% -$119K
EHT
2283
DELISTED
Eaton Vance 2021 Target Term Trust
EHT
$863K ﹤0.01%
85,710
+14,357
+20% +$141K
AMED
2284
DELISTED
Amedisys
AMED
$860K ﹤0.01%
7,083
-695
-9% -$82.5K
JRI icon
2285
Nuveen Real Asset Income & Growth Fund
JRI
$349M
$860K ﹤0.01%
50,784
+14,535
+40% +$236K
CLH icon
2286
Clean Harbors
CLH
$16.5B
$859K ﹤0.01%
12,084
+203
+2% +$14.1K
TSLF
2287
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$859K ﹤0.01%
56,315
-3,548
-6% -$55.1K
FTHI icon
2288
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.45B
$855K ﹤0.01%
38,266
+2,686
+8% +$59.1K
PBE icon
2289
Invesco Biotechnology & Genome ETF
PBE
$359M
$855K ﹤0.01%
15,984
-34,712
-68% -$1.8M
EMO
2290
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.05B
$854K ﹤0.01%
18,567
-721
-4% -$33.9K
MEDP icon
2291
Medpace
MEDP
$16.9B
$854K ﹤0.01%
13,060
-2,626
-17% -$151K
BG icon
2292
Bunge Global
BG
$21.4B
$853K ﹤0.01%
15,318
-1,743
-10% -$92.9K
SRT
2293
DELISTED
Startek Inc.
SRT
$853K ﹤0.01%
104,456
+3,404
+3% +$26K
GLOP
2294
DELISTED
GASLOG PARTNERS LP
GLOP
$850K ﹤0.01%
40,036
+2,891
+8% +$61.3K
LSI
2295
DELISTED
Life Storage, Inc.
LSI
$849K ﹤0.01%
13,394
-1,774
-12% -$114K
FTXL icon
2296
First Trust Nasdaq Semiconductor ETF
FTXL
$1.33B
$848K ﹤0.01%
+26,139
New +$844K
JHB
2297
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
$848K ﹤0.01%
85,617
+8,498
+11% +$83.6K
SWAV
2298
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$847K ﹤0.01%
+14,835
New +$720K
MSFT icon
2299
CALL
Microsoft
MSFT
$3.74T
$846K ﹤0.01%
170,100
+18,000
+12% +$2.29M
FPL
2300
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$846K ﹤0.01%
89,547
+375
+0.4% +$3.44K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.